Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients

2012 ◽  
Vol 36 (2) ◽  
pp. 251-257 ◽  
Author(s):  
Yuichi Inoue ◽  
Naohisa Uchimura ◽  
Kenji Kuroda ◽  
Koichi Hirata ◽  
Nobutaka Hattori
Keyword(s):  
Restless Legs Syndrome ◽  
Efficacy And Safety ◽  
Gabapentin Enacarbil ◽  
Restless Legs ◽  
Term Efficacy

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)

2008 ◽  
Vol 9 (5) ◽  
pp. 537-541 ◽  
Author(s):  
Markku Partinen ◽  
Kari Hirvonen ◽  
Leni Jama ◽  
Anniina Alakuijala ◽  
Christer Hublin ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Restless Legs ◽  
Term Efficacy

scholarly journals Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study

2010 ◽  
Vol 85 (6) ◽  
pp. 512-521 ◽  
Author(s):  
Richard K. Bogan ◽  
Michel A. Cramer Bornemann ◽  
Clete A. Kushida ◽  
Pierre V. Trân ◽  
Ronald W. Barrett
Keyword(s):  
Restless Legs Syndrome ◽  
Maintenance Treatment ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Gabapentin Enacarbil ◽  
Restless Legs ◽  
Randomized Controlled ◽  
Term Maintenance

scholarly journals Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment

2019 ◽  
Vol 55 ◽  
pp. 74-80 ◽  
Author(s):  
Diego Garcia-Borreguero ◽  
Irene Cano-Pumarega ◽  
Celia Garcia Malo ◽  
Jose Antonio Cruz Velarde ◽  
Juan José Granizo ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Gabapentin Enacarbil ◽  
Restless Legs

ENDOSCOPIC TREATMENT OF CHRONIC PANCREATITIS IN PEDIATRIC POPULATION: LONG-TERM EFFICACY AND SAFETY

2019 ◽  
Author(s):  
D Kohoutova ◽  
A Tringali ◽  
G Paparella ◽  
V Perri ◽  
I Boškoski ◽  
...  
Keyword(s):  
Chronic Pancreatitis ◽  
Endoscopic Treatment ◽  
Pediatric Population ◽  
Efficacy And Safety ◽  
Term Efficacy

Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy—104-Week VERTIS MET Trial

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1129-P
Author(s):  
SILVINA GALLO ◽  
BERNARD CHARBONNEL ◽  
ALLISON GOLDMAN ◽  
HARRY SHI ◽  
SUSAN HUYCK ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document